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Abstract
Introduction: Calciphylaxis is a rare but dreadful complication of chronic kidney disease. It is
characterized by nodular subcutaneous calcification and painful tissue necrosis which often results
in ulceration and secondary infection, leading to a high rate of mortality. Pathogenesis of this disease
is not well understood and there are very few, poorly studied treatment options for this disease.
Case presentation: We report a case of 60 year old Caucasian female with history of long
standing diabetes and chronic kidney disease stage 5 who presented with a very high calcium
phosphorous product, markedly elevated intact PTH levels and X-ray changes consistent with
diagnosis of calciphylaxis. Patient was initially managed by parathyroidectomy and later on was also
treated with intravenous sodium thiosulfate thrice weekly with each hemodialysis session for
duration of 10 weeks.
Conclusion: Patient had rapid and dramatic relief of her symptoms of pain. Treatment with
sodium thiosulfate was well tolerated without any side effects, accompanied by significant
symptomatic relief but without any effect on disease progression. So the role of sodium thiosulfate
in calciphylaxis is unknown and need further studies.
Introduction
Calciphylaxis is an inadequately understood syndrome of
vascular calcification and skin necrosis affecting around
1% of patients with end stage renal disease (ESRD) [1]. It
is thought to result from multiple comorbid factors. This
disease carries a very high morbidity and an extremely
high mortality rate. Young patients with prolonged dura-
tion of renal replacement therapy are the most commonly
affected patient population [2]. There are very few, poorly
studied treatment modalities reported in literature. We
report a case of a 60 year old female with a history of long
standing diabetes and chronic kidney disease that pre-
sented with painful skin lesions and was diagnosed with
calciphylaxis. In our patient, due to the lack of response to
more commonly described treatment strategies we uti-
lized the newly described but less studied treatment
modality of sodium thiosulfate which has reportedly
shown marked improvement in symptom control in liter-
ature [[3,4], and [5]].
Case report
A 60-year-old Caucasian woman with a history of stage 5
chronic kidney disease presented with complaints of
heaviness and pain in the medial aspect of left thigh,
worsening over seven days. She denied any fever, chills or
rigors. Past medical history was remarkable for coronary
artery disease, hypertension, well controlled Type II diabe-
tes mellitus diagnosed nine years ago, (hemoglobin A1C
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of 5.6, six months prior to presentation) and chronic kid-
ney disease stage 5 (glomerular filtration rate: 12 ml/min/
1.73 m2). Her medications included pioglitazone, furo-
semide, atenolol, lovastatin, lisinopril, isosorbide
mononitrate and metolazone. Physical exam revealed
some tenderness on the left thigh region but no edema or
erythema. She had palpable pulses bilaterally. Rest of the
physical exam was within normal limits. A doppler ultra-
sound performed on bilateral lower extremities was nega-
tive for deep vein thrombosis. Laboratory data revealed a
white blood cell count 13.1 thousand/mm3, hemoglobin
8.6 mg/dl, blood urea nitrogen 52 mmol/l, creatinine 4.7
mmol/l (baseline creatinine around 5.0 mmol/l), calcium
10.4 mmol/l, albumin 2.2 gm/dl, phosphorus 8 mmol/l
and a parathyroid hormone (PTH) level of 2138 pg/dl
(with a level of 1381 pg/dL 6 months prior) On the fifth
day of hospitalization, she started developing peridermal
necrotic areas along with erythema and tenderness in her
thigh (Figure 1). She was initially started on vancomycin
as the lesions were suspected to be secondary to local cel-
lulitis. However the absence of fever and the presence of a
markedly raised PTH levels along with the clinical picture
of widespread necrosis with erythema made calciphylaxis
a possibility. X-ray of left thigh was then obtained demon-
strating extensive vascular calcifications (figures 2 and Fig-
ure 3) thus making calciphylaxis highly likely on our list
of differential diagnosis. We did not perform biopsy of the
plaques as biopsy of a calciphylactic tissue is known to
precipitate ulceration and subsequent infection [6,7].
Patient was started on chronic renal replacement therapy
and pain control and discharged home to be followed up
as an outpatient. She presented back to the hospital
because of worsening left thigh ulceration and related
pain. Subtotal parathyroidectomy was then performed on
this hospitalization because of very high concentration of
parathyroid hormone. After parathyoidectomy, patient's
calcium phosphorus product decreased from 80 to 30.
Serum calcium and phosphorus had decreased to 8.2 mg/
dl and 3.7 mg/dl respectively. On out patient follow up
her serum intact parathyroid hormone level decreased
to19 pg/ml over a 2 month period. Her skin lesions con-
tinued to progress and she complained of significant pain
related to these lesions. We then performed a thorough lit-
erature review regarding various treatment options availa-
ble for calciphylaxis and had detailed discussion with the
patient regarding the same. Decision was made to try
sodium thiosulfate. She was administered sodium thio-
sulfate therapy 3 times weekly (25 g intravenously over 30
to 60 minutes) following each hemodialysis session. Over
the next 2 weeks patient had significant improvement in
her pain symptoms and marked decrease in analgesic
demand. She was then transferred to a nursing home with
continued use of sodium thiosulfate along with each
hemodialysis session. After 3 weeks patient was readmit-
ted to the hospital with worsening skin lesions extending
to involve her abdomen, buttocks and calf region in bilat-
eral lower extremities. Patient was continued on sodium
thiosulfate for 4 more weeks but her skin lesions contin-
Picture of left thigh at fifth day of hospitalization Figure 1
Picture of left thigh at fifth day of hospitalization.
X-ray of left thigh (AP view) showing extensive vascular Cal- cification Figure 2
X-ray of left thigh (AP view) showing extensive vas-
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ued to progress and deteriorate. Various other manage-
ment options were again discussed with the patient and
the decision was reached to keep her comfortable and her
management was transferred to hospice care
Discussion
Calciphylaxis or calcific uremic arteriolopathy is an extra-
osseous calcification of soft tissue and blood vessels and
is characterized by systemic medial calcification of the
arteries that leads to ischemia and skin and soft tissue
necrosis [8]. It is an uncommon but grave complication in
adult patients with chronic kidney disease (CKD) and end
stage renal disease. Calciphylaxis occurs in about 1% of
End stage renal disease patients each year [1]. It has a very
high 5 year mortality rate approaching as high as 65% [9].
The classic presentation may start with tender violaceous
or mottled skin lesions, plaques and/or subcutaneous
nodules which progress to ischemic non-healing deep
ulcers with subcutaneous fat necrosis. These may be com-
plicated by infection.
The pathogenesis of calciphylaxis is very poorly under-
stood hence making the treatment of this rare but fre-
quently fatal disease quite difficult. It is probably
multifactorial in etiology. It is more common in Cauca-
sian females. Commonly associated conditions in the
pathogenesis of calciphylaxis include obesity, hyperphos-
phatemia, an elevated calcium-phosphate product, sec-
ondary hyperparathyroidism, high alkaline phosphatase
and low serum albumin [9]. The most interesting fact is
that although these abnormalities are quite common in
patients with End stage renal disease, calciphylaxis is
rather uncommon. Various hypotheses have been postu-
lated regarding the pathogenesis of this disease including
vascular calcium deposition leading to tissue ischemia
[10]. This hypothesis has been supported by the fact that
the use of non-calcium based phosphate binders and
hemodialysis with low calcium dialysate has demon-
strated some benefit in some patients [11].
Diagnosis of this condition may sometimes be difficult
and requires a high index of clinical suspicion, particu-
larly in patients with renal impairment. Patients may have
high levels of PTH, calcium, phosphorous, calcium phos-
phorous product, alkaline phosphatase, urea and creati-
nine value however calciphylaxis may occur with normal
calcium and phosphate levels. Traditional radiographic
studies may demonstrate a 'pipe-stem' pattern of vascular
calcification. Also, xeroradiography may demonstrate cal-
cification of subcutaneous arterioles [12]. Bone scan is
another radio diagnostic study which may help in diagno-
sis and also to monitor disease progression Biopsy of the
lesions, which is considered gold standard, may reveal cal-
cification and endovascular fibrosis of small subcutane-
ous arteries and arterioles, which is sometimes associated
with infarction of the skin.
There are multiple differential diagnoses to be considered
for this condition including vasculitic syndromes, choles-
terol emboli syndrome, cryoglobulinemia, cryofibrino-
genemia, warfarin induced skin necrosis, disseminated
intravascular coagulation (DIC), nephrogenic fibrosing
dermopathy (NFD), scleromyxedema, type 1 primary
oxaluria, livedoid erythema, antiphospholipid antibody
syndrome, fungal infections, panniculitis, pyoderma gan-
grenosum, atherosclerotic peripheral vascular disease, cel-
lulitis and necrotizing fasciitis. Thus the diagnostic work
up in for this condition in doubtful cases may include
multiple diagnostic tests for the above mentioned condi-
tions based on clinical suspicions.
There are various treatment modalities described in litera-
ture which includes dietary modifications, use of non cal-
cium phosphorous binders and low calcium bath dialysis.
Calcimimetics and parathyriodectomy may be beneficial
in patients with hyperparathyroidism [13,14]. Some case
X-ray left thigh (lateral view) showing extensive vascular Cal- cification Figure 3
X-ray left thigh (lateral view) showing extensive vas-
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reports have discussed the use of hyperbaric oxygen. On
our literature review we did not come across any prospec-
tive controlled studies comparing various treatment
modalities. Recently, over the last few years, one of the
proposed therapies involves the use of sodium thiosul-
fates which increases the solubility of calcium deposits
[15]. Successful use of this agent has been reported for
managing nephrolithiasis [15] and tumoral calcinosis [8].
The success of sodium thiosulfate therapy in patients with
calciphylaxis has been described in several case reports
and case series with improvement in symptoms and heal-
ing of the ulcers [[3,4], and [5]].
Sodium thiosulfate pentahydrate (Na2S2O3) has a molec-
ular weight of 248 (KDa) and has a neutral pH in water. It
distributes throughout extracellular fluids and is excreted
unchanged in the urine, as is described in normal animals.
It has been classically used as an antidote for acute cya-
nide poisoning and as a topical agent in treatment for
acne and pityriasis versicolor. Sodium thiosulfate reacts
with calcium resulting in a calcium thiosulfate salt of
extremely high soluability [15]. Calcium thiosulfate is
3600 times more soluble than calcium phosphate [15]. In
patients with ESRD on hemodialysis sodium thiosulfate is
probably eliminated via biliary secretion.
Our patient was diagnosed with calciphylaxis based on
the overall clinical picture including symptoms, signs,
progression of the lesions and characteristic radiographic
findings. Although biopsy is considered gold standard for
diagnosis it was not performed in our patient given the
high likelihood of clinical suspicion and the fear of caus-
ing ulceration and infection. Our patient had debilitating
calciphylactic lesions with very high intact PTH levels. Ini-
tial unsuccessful trial of renal replacement therapy was
done without much clinical benefit to the patient. There-
after parathyroidectomy was performed with the thought
process that it decreases the calcium phosphorous product
but again was clinically unsuccessful. Later on she was
also treated with sodium thiosulfate with the rationale
that it may solubilize the calcium deposits. Our patient
did have the benefit of drastic pain relief but unfortu-
nately the progression of disease and skin lesions was
unaffected, unlike the cases described in the literature. The
reason for this may be related to the rarity of reporting of
this condition and paucity of comparative studies or
maybe a reflection of the relative low reporting of negative
outcomes.
Conclusion
Calciphylaxis persists to be a dreadful condition, with
poorly understood pathophysiology. The ideal treatment
of this disease is unknown because of its rarity and the
lack of prospective clinical trials. Sodium thiosulfate
seems to be of some clinical benefit in adult patients with
calciphylaxis. It is well tolerated and has minimal adverse
effects. Further prospective studies are needed to establish
the role of sodium thiosufate in the treatment of this
entity. We believe that though our patient did not have an
effect on disease progression she had rapid improvement
in her symptoms following administration of sodium thi-
osulfate.
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